Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sarcoma
>>
EGFR
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
3
6
9
12
15
18
21
24
27
30
erlotinib
/ Generic mfg.
gefitinib
/ Generic mfg.
Caprelsa
(vandetanib) / Sanofi
ganetespib
(ADX-1612) / Aldeyra
Gilotrif
(afatinib) / Boehringer Ingelheim
Pexa-Vec
(pexastimogene devacirepvec) / SillaJen, Transgene
Nerlynx
(neratinib) / Puma
Tagrisso
(osimertinib) / AstraZeneca
